申请人:Edlin Christopher D.
公开号:US20080096884A1
公开(公告)日:2008-04-24
Compounds of formula (I)
or pharmaceutically acceptable salts thereof are inhibitors of phosphodiesterase type IV (PDE4) and are of use in the treatment of inflammatory and/or allergic diseases.